Needham & Company Starts Medidata Solutions (MDSO) at Buy; “SaaSifying” The Clinical Trials World
Tweet Send to a Friend
Needham & Company initiates coverage on Medidata Solutions (NASDAQ: MDSO) with a Buy. PT $35.
Needham analyst says, "MDSO is ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham analyst says, "MDSO is ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
